Can J Neurol Sci. 2004 Feb;31(1):64-71
Moore F, Wolfson C, Alexandrov L, Lapierre Y.
Department of Neurology, Jewish General Hospital, Montreal, QC, Canada.
Quality of life instruments provide information that traditional outcome measures used in studies of multiple sclerosis do not.
It is unclear if longer, disease-specific instruments provide more useful information than shorter, more general instruments, or whether patients prefer one type to another.
We conducted a cross-sectional study of quality of life in a multiple sclerosis clinic population using a mailed questionnaire that combined three different quality of life instruments; the SF-36, the Multiple Sclerosis Quality of Life Instrument-54, and the EuroQol EQ-5D.
We assessed the feasability of using each instrument and patient preference for each, calculated correlation coefficients for the summary scores of each instrument and other measures of disease severity, and calculated odds ratios from proportional odds models comparing each instrument with the Expanded Disability Status Scale.
We did not find substantial differences between the three instruments.
All were well-received by patients, and over 75% felt that the combination of the three instruments best assessed their quality of life.
For each instrument there was substantial variability between patients with similar quality of life scores in terms of their disability (as assessed by the Expanded Disability Status Scale and their own perception of their disease severity and quality of life (on simple 1-10 scales).
Quality of life instruments are easy to use and well-received by patients, regardless of their length.
There do not appear to be clinically important differences between general and disease-specific instruments.
Each instrument appears to measure something other than a patient's disability or perception of their own disease severity or quality of life.